IHS Chemical Week

EnviroTech :: R&D

Almac Expects High Sales Growth, Especially in U.S.

9:25 AM MST | February 25, 2008 | Alex Scott

Almac (Craigavon, U.K.), a privately owned pharmaceutical services group, says it is on track to grow sales significantly during the next few years and in the U.S. in particular. Group sales increased 16% in 2007, to £150.1 million ($293 million), and are expected to rise a further 20% this year, the company said at a press briefing, held recently at its Craigavon headquarters. Almac says its long-term goal is to expand its U.S. market presence. The firm’s largest single capital investment this year is a proposed $100-million project to build a U.S...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa